Forte Biosciences, Inc.

Historical 13F Holders

Symbol
FBRX
CUSIP
34962G109
All holders as of
Q2 2024
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 34962G109 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Farallon Capital Partners, L.P. 13G/A
3.4% 2/10/2025
Event 12/31/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2024 Q2 35 19.1 M $10.2M
2024 Q1 34 19.1 M $13.3M
2023 Q4 36 18.9 M $15.5M
2023 Q3 33 16.7 M $11.1M
2023 Q2 32 3.47 M $3.60M
2023 Q1 32 3.93 M $3.97M
2022 Q4 35 3.84 M $3.84M
2022 Q3 35 2.67 M $2.85M
2022 Q2 41 2.31 M $3.01M
2022 Q1 54 3.93 M $6.83M
2021 Q4 56 5.47 M $12.8M
2021 Q3 60 3.91 M $12.8M
2021 Q2 76 9.29 M $312M
2021 Q1 63 8.65 M $297M
2020 Q4 51 8.39 M $306M
2020 Q3 48 6.80 M $330M
2020 Q2 30 2.88 M $42.1M
2020 Q1 1 66.0 $2.00k
2019 Q4 1 66.0 $2.00k
2019 Q3 1 66.0 $2.00k
2019 Q2 1 66.0 $2.00k
2019 Q1 1 66.0 $2.00k